Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 380, Issue 15, Pages 1483-1485Publisher
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc1813435
Keywords
-
Categories
Funding
- Janssen Research and Development
Ask authors/readers for more resources
A preliminary analysis of a trial involving participants with brain amyloid deposition who are at risk for dementia due to Alzheimer's disease showed no benefit of a beta-secretase enzyme inhibitor over placebo and a potential signal of worse cognitive test scores over 3 and 6 months.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
